Search Close Search
Search Close Search
Page Menu

Paul Peters Ph.D.

Ph.D.: 1996, Purdue University
Postdoctoral research: University of Missouri
Office: UMass Chan Medical School
364 Plantation Street, LRB-570-K
Worcester, MA 01605
Phone: 508-856-5824


SERINC3 and SERINC5 are novel anti-viral host proteins that inhibit HIV-1 infectivity and are counteracted by the accessory HIV-1 protein Nef. My research examines how SERINCs affect HIV-1 virus particles, and how Nef downregulates them to prevent their uptake into HIV-1 particles. This research is relevant to public health, because inhibiting the downregulation of SERINCs by Nef is a potential strategy to combat HIV/AIDS.